Evidence map›Paper›PMID 31450557›Full record

ArticleMarine drugs2019

The Spirocyclic Imine from a Marine Benthic Dinoflagellate, Portimine, Is a Potent Anti-Human Immunodeficiency Virus Type 1 Therapeutic Lead Compound.

Mai Izumida, Koushirou Suga, Fumito Ishibashi, Yoshinao Kubo

Abstract read
In one paragraph

Article in Marine drugs, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed.

  1. Review
  2. Article
  3. Review
  4. Review
  5. Article
  6. Article
  7. Review
  8. Review
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Mai IzumidaDepartment of Clinical Medicine, Institute of Tropical Medicine, Nagasaki University, Nagasaki 852-8523, Japan. maimomonga@yahoo.co.jp.
Koushirou SugaGraduate School of Fisheries and Environmental Sciences, Nagasaki University, Nagasaki 852-8521, Japan.
Fumito IshibashiGraduate School of Fisheries and Environmental Sciences, Nagasaki University, Nagasaki 852-8521, Japan.
Yoshinao KuboProgram for Nurturing Global Leaders in Tropical Medicine and Emerging Communicable Diseases, Graduate School of Biomedical Sciences, Nagasaki University, Nagasaki 852-8523, Japan. yoshinao@nagasaki-u.ac.jp.

Funding

Japan Agency for Medical Research and Development JP18fk0410004Japan Society for the Promotion of Science 15K08499Japan Society for the Promotion of Science 18k16773MSD Life Science Foundation, Public Interest Incorporated Foundation 17MFRGA08
6 · The paper itself

Abstract

In this study, we aimed to find chemicals from lower sea animals with defensive effects against human immunodeficiency virus type 1 (HIV-1). A library of marine natural products consisting of 80 compounds was screened for activity against HIV-1 infection using a luciferase-encoding HIV-1 vector. We identified five compounds that decreased luciferase activity in the vector-inoculated cells. In particular, portimine, isolated from the benthic dinoflagellate

Indexed as

Anti-HIV AgentsAquatic OrganismsDinoflagellidaDrug Evaluation, PreclinicalHEK293 CellsHeLa CellsHIV-1HIV InfectionsHumansIminesInhibitory Concentration 50Spiro CompoundsVirus ReplicationAnti-HIV AgentsIminesportimineSpiro CompoundsHIV-1portiminereverse transcriptaseVulcanodinium rugosum

Identifiers

PMID31450557
PMCPMC6780162

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.